2019•Journal of Thoracic OncologyOpen access

EP1.14-10 Investigation of Mechanisms of Acquired Resistance to Afatinib with Plasma DNA in Non-Small Cell Lung Cancer Patients

Naoko Sueoka‐Aragane, Tomomi Nakamura, Chiho Nakashima, Ken Iwanaga, Hitomi Umeguchi

Open full text 0 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Afatinib, Osimertinib, T790M, Medicine, Lung cancer, Epidermal growth factor receptor, Acquired resistance, Oncology

Back to paper search Browse research topics Original source

EP1.14-10 Investigation of Mechanisms of Acquired Resistance to Afatinib with Plasma DNA in Non-Small Cell Lung Cancer Patients — Research Paper | ScholarLens